Display options
Cite
Cabé J, Brousse G, Pereira B, et al. Influence of Clinical Markers of Dopaminergic Behaviors on Depressive Symptoms During Withdrawal in Cocaine Users. Front Psychiatry. 2021;12:775670doi: 10.3389/fpsyt.2021.775670.
Cabé, J., Brousse, G., Pereira, B., Cabé, N., Karsinti, E., Zerdazi, E. H., Icick, R., Llorca, P. M., Bloch, V., Vorspan, F., & De Chazeron, I. (2021). Influence of Clinical Markers of Dopaminergic Behaviors on Depressive Symptoms During Withdrawal in Cocaine Users. Frontiers in psychiatry, 12775670. https://doi.org/10.3389/fpsyt.2021.775670
Cabé, Julien, et al. "Influence of Clinical Markers of Dopaminergic Behaviors on Depressive Symptoms During Withdrawal in Cocaine Users." Frontiers in psychiatry vol. 12 (2021): 775670. doi: https://doi.org/10.3389/fpsyt.2021.775670
Cabé J, Brousse G, Pereira B, Cabé N, Karsinti E, Zerdazi EH, Icick R, Llorca PM, Bloch V, Vorspan F, De Chazeron I. Influence of Clinical Markers of Dopaminergic Behaviors on Depressive Symptoms During Withdrawal in Cocaine Users. Front Psychiatry. 2021 Nov 22;12:775670. doi: 10.3389/fpsyt.2021.775670. eCollection 2021. PMID: 34880796; PMCID: PMC8645893.
Copy Download .nbib Format: NLM
Share it on

Front Psychiatry. 2021 Nov 22;12:775670. doi: 10.3389/fpsyt.2021.775670. eCollection 2021.

Influence of Clinical Markers of Dopaminergic Behaviors on Depressive Symptoms During Withdrawal in Cocaine Users.

Frontiers in psychiatry

Julien Cabé, Georges Brousse, Bruno Pereira, Nicolas Cabé, Emily Karsinti, El-Hadi Zerdazi, Romain Icick, Pierre M Llorca, Vanessa Bloch, Florence Vorspan, Ingrid De Chazeron

Affiliations

  1. Service d'addictologie et pathologies duelles, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France.
  2. Université Clermont Auvergne, CHU, CNRS, Clermont Auvergne INP, Institut Pascal, Clermont-Ferrand, France.
  3. Faculté de Médecine, Université Clermont Auvergne, Clermont-Ferrand, France.
  4. Direction de la Recherche Clinique et des Innovations, CHU Clermont-Ferrand, Clermont-Ferrand, France.
  5. Normandie University, UNICAEN, PSL Université de Paris, EPHE, INSERM, U1077, CHU de Caen, GIP Cyceron, Neuropsychologie et Imagerie de la Mémoire Humaine, Caen, France.
  6. Service d'Addictologie, Centre Hospitalier Universitaire de Caen, Caen, France.
  7. INSERM UMR-S 1144, Université de Paris, Optimisation Thérapeutique en Neuropsychopharmacologie, Paris, France.
  8. Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, Assistance Publique-Hôpitaux de Paris, Paris, France.
  9. Service de Psychiatrie B, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France.
  10. Faculté de Médecine, Université de Paris, Paris, France.

PMID: 34880796 PMCID: PMC8645893 DOI: 10.3389/fpsyt.2021.775670

[No abstract available.]

Copyright © 2021 Cabé, Brousse, Pereira, Cabé, Karsinti, Zerdazi, Icick, Llorca, Bloch, Vorspan and De Chazeron.

Keywords: clinical markers; cocaine; depressive symptoms; dopamine; withdrawal

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Psychopharmacology (Berl). 2015 Mar;232(6):1003-10 - PubMed
  2. Neurosci Biobehav Rev. 1985 Fall;9(3):469-77 - PubMed
  3. Parkinsons Dis. 2011;2011:485063 - PubMed
  4. Psychiatry Res. 2012 Dec 30;200(2-3):1074-6 - PubMed
  5. Eur Psychiatry. 2013 Mar;28(3):141-6 - PubMed
  6. Lancet Neurol. 2009 May;8(5):464-74 - PubMed
  7. Psychopharmacol Bull. 1998;34(1):117-21 - PubMed
  8. Neurosci Biobehav Rev. 2013 Sep;37(8):1838-59 - PubMed
  9. Can Med Assoc J. 1969 Dec 27;101(13):59-68 - PubMed
  10. Curr Neuropharmacol. 2017 Apr;15(3):409-416 - PubMed
  11. Drug Alcohol Depend. 2017 Dec 1;181:63-70 - PubMed
  12. Drug Alcohol Depend. 2001 Aug 1;63(3):207-14 - PubMed
  13. Drug Alcohol Depend. 2001 Jul 1;63(2):131-7 - PubMed
  14. N Engl J Med. 1969 Feb 13;280(7):337-45 - PubMed
  15. J Gen Intern Med. 2003 Jan;18(1):1-8 - PubMed
  16. Mov Disord. 2008 Jan 30;23(2):183-9; quiz 313 - PubMed
  17. J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):636-42 - PubMed
  18. Biometrics. 1984 Dec;40(4):1079-87 - PubMed
  19. Addiction. 2002 Jan;97(1):75-85 - PubMed
  20. Am J Psychiatry. 1999 Sep;156(9):1444-6 - PubMed
  21. J Clin Psychiatry. 2006 Feb;67(2):247-57 - PubMed
  22. Am J Ophthalmol. 2000 Aug;130(2):261-2 - PubMed
  23. Compr Psychiatry. 2009 May-Jun;50(3):245-50 - PubMed
  24. Am J Addict. 2009 Sep-Oct;18(5):339-45 - PubMed
  25. Nature. 1997 Apr 24;386(6627):827-30 - PubMed
  26. J Neurol Sci. 2021 Jan 15;420:117252 - PubMed
  27. Am J Addict. 2006 Jul-Aug;15(4):278-85 - PubMed
  28. Drug Alcohol Depend. 2008 Nov 1;98(1-2):13-23 - PubMed
  29. J Affect Disord. 1979 Dec;1(4):255-67 - PubMed
  30. Rev Neurol (Paris). 2009 Nov;165(11):845-56 - PubMed
  31. Psychiatry Res. 2018 Jun;264:210-216 - PubMed
  32. Mov Disord. 2001 Nov;16(6):1175-6 - PubMed
  33. Drug Alcohol Depend. 2005 Oct 1;80(1):23-33 - PubMed
  34. Int J Neurosci. 2001;106(3-4):253-63 - PubMed
  35. Encephale. 2009 Dec;35 Suppl 7:S264-8 - PubMed
  36. Adv Neurol. 2005;96:42-55 - PubMed
  37. Curr Top Behav Neurosci. 2010;3:119-78 - PubMed
  38. J Subst Abuse. 1995;7(4):481-97 - PubMed
  39. Drug Alcohol Depend. 1998 Sep 1;52(1):1-13 - PubMed
  40. Biol Psychiatry. 2014 Nov 15;76(10):802-9 - PubMed

Publication Types